TY - JOUR
KW - 5-alpha reductase inhibitors
KW - benign prostatic hyperplasia
KW - alpha-blockers
KW - cardiovascular safety
KW - Cohort study
KW - heart failure
AU - H. Ayele
AU - P. Reynier
AU - L. Azoulay
AU - R. Platt
AU - J. Cabaussel
AU - S. Benayoun
AU - K. Filion
AD - Department of Epidemiology, Biostatistics, Occupational Health, McGill University, Montreal, Quebec, Canada; Center for Clinical Epidemiology, Lady Davis Institute, Jewish General Hospital, Montreal, Quebec, Canada; Department of Pediatrics, McGill University, Montreal, Quebec, Canada.
Center for Clinical Epidemiology, Lady Davis Institute, Jewish General Hospital, Montreal, Quebec, Canada; Department of Pediatrics, McGill University, Montreal, Quebec, Canada.
Department of Epidemiology, Biostatistics, Occupational Health, McGill University, Montreal, Quebec, Canada; Center for Clinical Epidemiology, Lady Davis Institute, Jewish General Hospital, Montreal, Quebec, Canada; Gerald Bronfman Department of Oncology, McGill University, Montreal, Quebec, Canada; Department of Pediatrics, McGill University, Montreal, Quebec, Canada.
Department of Surgery, Urology Unit, Hôpital Maisonneuve-Rosemont, Montreal, Canada; Department of Pediatrics, McGill University, Montreal, Quebec, Canada.
Department of Epidemiology, Biostatistics, Occupational Health, McGill University, Montreal, Quebec, Canada; Center for Clinical Epidemiology, Lady Davis Institute, Jewish General Hospital, Montreal, Quebec, Canada; Department of Medicine, McGill University, Montreal, Quebec, Canada; Department of Pediatrics, McGill University, Montreal, Quebec, Canada. Electronic address: kristian.filion@mcgill.ca.
AN - 37481022
BT - Am J Med
DO - 10.1016/j.amjmed.2023.06.021
DP - NLM
ET - 2023/07/23
LA - eng
N1 - 1555-7162
Ayele, Henok Tadesse
Reynier, Pauline
Azoulay, Laurent
Platt, Robert W
Cabaussel, Josselin
Benayoun, Serge
Filion, Kristian B
Journal Article
United States
Am J Med. 2023 Jul 20:S0002-9343(23)00431-X. doi: 10.1016/j.amjmed.2023.06.021.
PY - 2023
SN - 0002-9343
T2 - Am J Med
TI - The Cardiovascular Safety of 5-Alpha-Reductase Inhibitors Among Men with Benign Prostatic Hyperplasia: A Population-Based Cohort Study
ER -